Effects of color-enhancing glasses on color vision in congenital red-green color deficiencies.


Journal

Optics express
ISSN: 1094-4087
Titre abrégé: Opt Express
Pays: United States
ID NLM: 101137103

Informations de publication

Date de publication:
15 Aug 2022
Historique:
entrez: 15 10 2022
pubmed: 16 10 2022
medline: 19 10 2022
Statut: ppublish

Résumé

As commercially available glasses for color vision deficiency (CVD) are classified as low risk, they are not subject to stringent marketing regulations. We investigate how EnChroma and VINO glasses affect performance on the Colour Assessment and Diagnosis (CAD) test in individuals with CVD. Data were obtained from 51 individuals with red-green CVD. Blood or saliva samples were collected to examine the structure of the OPN1LW/OPN1MW array. Individuals completed the CAD test twice without glasses and once with each pair of glasses. Although there was a statistically significant effect of both glasses, only that of VINO could be considered functionally meaningful.

Identifiants

pubmed: 36242206
pii: 491334
doi: 10.1364/OE.451295
pmc: PMC9576280
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

31182-31194

Subventions

Organisme : NCRR NIH HHS
ID : C06 RR016511
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY017607
Pays : United States

Références

Curr Biol. 2020 Aug 3;30(15):3011-3015.e4
pubmed: 32589909
Science. 1986 Apr 11;232(4747):193-202
pubmed: 2937147
Science. 1986 Apr 11;232(4747):203-10
pubmed: 3485310
Nano Lett. 2022 Mar 9;22(5):2094-2102
pubmed: 35226508
Neuron. 2002 Aug 15;35(4):783-92
pubmed: 12194876
Vision Res. 1995 Mar;35(6):739-56
pubmed: 7740766
Am J Optom Physiol Opt. 1985 Feb;62(2):105-10
pubmed: 3872597
Cold Spring Harb Perspect Med. 2014 Aug 21;4(11):a017418
pubmed: 25147187
J Opt Soc Am A Opt Image Sci Vis. 2008 Dec;25(12):2918-24
pubmed: 19037381
Neuron. 1994 May;12(5):1131-8
pubmed: 8185948
Nat Neurosci. 1999 Oct;2(10):884-8
pubmed: 10491608
Opt Express. 2019 Jun 24;27(13):17954-17967
pubmed: 31252746
Vision Res. 2000;40(13):1711-37
pubmed: 10814758
Vision Res. 2011 Oct 15;51(20):2224-33
pubmed: 21893078
Vis Neurosci. 2004 May-Jun;21(3):205-16
pubmed: 15518190
Vis Neurosci. 2004 May-Jun;21(3):461-3
pubmed: 15518230
Vision Res. 2011 Apr 13;51(7):633-51
pubmed: 21167193
Opt Express. 2018 Oct 29;26(22):28693-28703
pubmed: 30470042
Vision Res. 2021 Jun;183:1-15
pubmed: 33636681
Vision Res. 1974 Nov;14(11):1237-44
pubmed: 4428632
J Physiol. 1987 Sep;390:145-60
pubmed: 3443931
J Vis. 2009 Feb 25;9(2):20.1-16
pubmed: 19271930
Vis Neurosci. 2004 May-Jun;21(3):477-82
pubmed: 15518233
J Opt Soc Am A Opt Image Sci Vis. 2020 Apr 1;37(4):A133-A144
pubmed: 32400533
J Opt Soc Am A Opt Image Sci Vis. 1995 Oct;12(10):2219-29
pubmed: 7500202
Behav Genet. 1996 May;26(3):195-207
pubmed: 8754247
Ophthalmic Physiol Opt. 2006 Mar;26(2):137-47
pubmed: 16460314
Nature. 2009 Oct 8;461(7265):784-7
pubmed: 19759534
Ophthalmic Physiol Opt. 2010 Sep;30(5):685-92
pubmed: 20883355
J Vis. 2014 Nov 20;14(13):19
pubmed: 25413625

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH